Digital health / tele
Access, chronic care, triage, care navigation
Back to Sectors01 02 03 04 05 01 02 03 04 05 06
Sector guide · Guide 5 of 10
Healthcare / Medtech
Healthtech, care delivery, diagnostics, medtech, and wellness, longer cycles, proof bars, and how to raise credibly in India.
164matching funds
Open in directory01, Context
What this sector means
Healthcare investors in India span digital health, care delivery networks, diagnostics, medtech devices, pharma-adjacent software, and consumer wellness. Timelines are often longer than pure software. Clinical validation, provider adoption, trust, and regulation sit beside product and growth.
Investors ask who pays (patient, employer, insurer, hospital), whether outcomes or cost savings are real, and how you acquire providers or patients without unsustainable subsidies. Device and deep-science stories need stronger evidence packages; consumer wellness needs retention and brand clarity that survives fads.
A credible raise matches capital to milestones: clinical, regulatory, distribution, or unit-economics proofs. Do not hide the long cycle, show why this team can navigate hospitals, doctors, and compliance, and what this round specifically de-risks.
Timelines are often longer than pure software.
02, At a glance
Sector snapshot
How this category usually shows up for Indian founders raising capital.
Typical cheque
Varies; clinical paths need runwayPrimary buyer
Patients, providers, employers, payorsDiligence focus
Outcomes, adoption, who pays, regulationIndia edge
Access gaps + digital public railsCapital types
Health VCs, impact, FO, strategics03, Map
Landscape map
Pick the sub-sector narrative before you shortlist funds.
Care delivery
Clinics, specialty chains, home care
Diagnostics
Labs, imaging, at-home testing workflows
Medtech / devices
Hardware + software with clinical proof
Wellness & consumer health
Retention-led products with real outcomes
04, Scoreboard
Metrics that matter
Bring the ones that match your model.
Clinical / outcome signal
Core healthcare truth
Provider or patient retention
Adoption quality
Cost to serve
Unit economics of care
Who pays & collection
Revenue reality
Utilization / adherence
Engagement beyond signup
Regulatory milestone progress
De-risk path
05, Weights
How investors weigh diligence
Relative emphasis in partner conversations, directional, not a formula.
Clinical credibilityEvidence, advisors, protocol quality
93
Go-to-market to providersSales cycle into hospitals/clinics
85
Payment modelCash, insurance, employer, B2B
82
Regulatory pathWhat must be true to scale
80
Ops excellenceQuality, safety, staffing
74
06, Fit
Who it fits
- Digital health teams with provider or patient proof
- Medtech founders with validation milestones mapped
- Care delivery operators with unit economics visibility
- Wellness products with retention and outcome claims that hold
Who should wait
- Apps with downloads but no care pathway or outcomes
- Device ideas without clinical or manufacturing plan
- Founders allergic to regulation and hospital reality
- “AI diagnosis” claims without clinical governance
07, Checklist
What investors look for
Use this before outreach, not after the first rejection.
- Clear clinical or operational problem ownership
- Evidence of outcomes or cost reduction
- A realistic adoption path through providers or employers
- Payment and collection honesty
- Regulatory and safety awareness
- Team mix: clinical + product + ops
08, Pack
What to prepare
- Evidence pack: pilots, studies, advisor letters
- Care pathway diagram and who pays at each step
- Regulatory milestone map tied to the raise
- Unit economics of delivery / acquisition
- Risk register: clinical, legal, ops
09, Playbook
Fundraising playbook
- State the clinical claim carefully, precision builds trust
- Match investor type to risk (device ≠ consumer wellness)
- Raise against milestones, not open-ended R&D
- Bring a clinician into key diligence calls when relevant
- Separate science risk from distribution risk in the deck
- Show why India is the right first market
10, Watchouts
Common mistakes
01
Overclaiming clinical efficacy early
02
Ignoring who pays until the last slide
03
Underestimating hospital sales cycles
04
Consumer growth tactics that break trust in care
05
Raising too little for a regulatory-heavy path
11, Capital map
Funds in this sector
Accelerator
100Unicorns
Be the 'Y Combinator of India', provide initial capital plus committed follow-on to idea-stage startups, supporting them across their first three funding rounds before connecting them to large VCs for growth capital.
$250K – $3MSyndicate / Network
77 Capital
77 Capital backs early-stage Indian startups at Pre-Seed and Seed stages, focusing on SaaS, B2B marketplaces, FinTech, and HealthTech through a syndicate model that brings together aligned capital and operator networks.
$75K – $100KVenture Capital
8X Ventures
DeepTech-focused VC backing startups with strong scientific and research foundations that can fundamentally transform industries and economies; invests and enables, leveraging Middle East and Europe relationships to help portfolio companies expand globally and raise larger follow-on rounds.
$241K – $602KContinue